<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">20616</article-id><article-id pub-id-type="doi">10.7554/eLife.20616</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Adequate immune response ensured by binary IL-2 and graded CD25 expression in a murine transfer model</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-67233"><name><surname>Fuhrmann</surname><given-names>Franziska</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-64078"><name><surname>Lischke</surname><given-names>Timo</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0413-4252</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-67234"><name><surname>Gross</surname><given-names>Fridolin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-67235"><name><surname>Scheel</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-76126"><name><surname>Bauer</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-67236"><name><surname>Kalim</surname><given-names>Khalid Wasim</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-67237"><name><surname>Radbruch</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-67238"><name><surname>Herzel</surname><given-names>Hanspeter</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0414-7889</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-67239"><name><surname>Hutloff</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-65278"><name><surname>Baumgrass</surname><given-names>Ria</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3289-1608</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Robert Koch Institute</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">German Rheumatism Research Center Berlin (DRFZ)</institution>, <institution>A Leibniz Institute</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Institute for Theoretical Biology</institution>, <institution>Charité University Medicine</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Charité University Medicine</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dustin</surname><given-names>Michael L</given-names></name><role>Reviewing editor</role><aff id="aff5"><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><email>baumgrass@drfz.de</email></corresp><fn fn-type="con" id="equal-contrib"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><elocation-id>e20616</elocation-id><history><date date-type="received"><day>14</day><month>08</month><year>2016</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Fuhrmann et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Fuhrmann et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-20616-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.20616.001</object-id><p>The IL-2/IL-2Ralpha (CD25) axis is of central importance for the interplay of effector and regulatory T cells. Nevertheless, the question how different antigen loads are translated into appropriate IL-2 production to ensure adequate responses against pathogens remains largely unexplored. Here we find that at single cell level, IL-2 is binary (digital) and CD25 is graded expressed whereas at population level both parameters show graded expression correlating with the antigen amount. Combining in vivo data with a mathematical model we demonstrate that only this binary IL-2 expression ensures a wide linear antigen response range for Teff and Treg cells under real spatiotemporal conditions. Furthermore, at low antigen concentrations binary IL-2 expression safeguards by its spatial distribution selective STAT5 activation only of closely adjacent Treg cells regardless of their antigen specificity. These data show that the mode of IL-2 secretion is critical to tailor the adaptive immune response to the antigen amount.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.001">http://dx.doi.org/10.7554/eLife.20616.001</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>adaptive immune response</kwd><kwd>Th cell activation</kwd><kwd>TCR signaling</kwd><kwd>cytokine expression</kwd><kwd>systems biology</kwd><kwd>reaction-diffusion model</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id><institution>Bundesministerium für Bildung und Forschung</institution></institution-wrap></funding-source><award-id>T-Sys (e:Bio)</award-id><principal-award-recipient><name><surname>Radbruch</surname><given-names>Andreas</given-names></name><name><surname>Herzel</surname><given-names>Hanspeter</given-names></name><name><surname>Baumgrass</surname><given-names>Ria</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB650</award-id><principal-award-recipient><name><surname>Baumgrass</surname><given-names>Ria</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>TR52</award-id><principal-award-recipient><name><surname>Baumgrass</surname><given-names>Ria</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A murine adoptive transfer model shows that binary IL-2 and graded CD25 expression tailor the T helper cell response to the antigen amount in vivo.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The adaptive immune response of healthy vertebrates can be adjusted to match the overall severity of a pathogen. At the population level, T cells translate a total pathogen input into an adequate cytokine response over a large dynamic range. Individual T cells sense both antigen affinity and frequency and tailor the collective antigen-specific T cell activation to the antigen amount (<xref ref-type="bibr" rid="bib1">Allison et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Gottschalk et al., 2012</xref>; <xref ref-type="bibr" rid="bib15">Kellogg et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Miskov-Zivanov et al., 2013</xref>). The cytokine IL-2 and its signaling are of central importance for these processes. IL-2 is mainly produced by activated Foxp3<sup>−</sup> CD4<sup>+</sup> T helper cells (hereinafter referred to as 'Th cells') and mediates diverse pleiotropic actions such as promotion of Th1 and Th2 differentiation, expansion of multiple Th cell populations, as well as generation and maintenance of Foxp3<sup>+</sup> regulatory T cells (Treg cells) (<xref ref-type="bibr" rid="bib21">Liao et al., 2013</xref>). Thus, IL-2 positively acts on Th cells through synergistic effects between antigen and cytokines and negatively through preferred binding to and activation of Foxp3<sup>+</sup> Treg cells.</p><p>There are a number of in vitro studies, some of them even combined with mathematical modeling, to dissect the dichotomic effect of IL-2 signaling in effector Th cells and Foxp3<sup>+</sup> Treg cells (<xref ref-type="bibr" rid="bib6">Benary et al., 2008</xref>; <xref ref-type="bibr" rid="bib7">Bendfeldt et al., 2012</xref>; <xref ref-type="bibr" rid="bib8">Busse et al., 2010</xref>; <xref ref-type="bibr" rid="bib12">Feinerman et al., 2010</xref>; <xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Voisinne et al., 2015</xref>). Observations from various knock-out mice (e.g. IL-2Rα, STAT5) and other in vivo studies, however, have challenged some conclusions of these in vitro data and underlined the importance of local antigen concentrations, temporal aspects, cytokine compositions, cell heterogeneity in tissues and much more for the biological outcome orchestrated by IL-2 during an immune response (reviewed in <xref ref-type="bibr" rid="bib21">Liao et al., 2013</xref>).</p><p>There are several articles dealing with certain molecular features of the IL-2 pathway in vivo, such as: First, Sojka et al. studied the kinetics of IL-2 secretion by naive and memory Th cells (<xref ref-type="bibr" rid="bib35">Sojka et al., 2004</xref>) and some studies observed a paracrine IL-2 action on STAT5 activation (<xref ref-type="bibr" rid="bib24">Long and Adler, 2006</xref>; <xref ref-type="bibr" rid="bib29">O'Gorman et al., 2009</xref>; <xref ref-type="bibr" rid="bib33">Sabatos et al., 2008</xref>). Second, Amado et al. proposed that IL-2 is sensed by both the activated Th cell pool and by Treg cells, which reciprocally regulate cells of the IL-2-producing cell subset in IL-2 reporter mice (<xref ref-type="bibr" rid="bib4">Amado et al., 2013</xref>). Third, O’Gorman et al. showed that in the initial phase of antigen-specific activation IL-2-dependent STAT5 phosphorylation occurred primarily in Treg cells (<xref ref-type="bibr" rid="bib29">O'Gorman et al., 2009</xref>). Fourth, Liu et al. underscored the importance of a fine-tuned local IL-2 availability to limit otherwise constant damage from activated auto-responsive Th cells under steady state conditions (<xref ref-type="bibr" rid="bib23">Liu et al., 2015</xref>).</p><p>However, in all of these studies the antigen load-dependent IL-2 expression and IL-2 signaling via CD25/STAT5 in both antigen-specific as well as endogenous Th and Treg cells was not continuously monitored in vivo. Furthermore, there is the open question whether a graded antigen load is translated into binary (also known as digital, all-or-none, switch-like, or bimodal) or graded expression of TCR-dependent genes coding for important cytokines and receptors such as IL-2 and CD25 or CD69, respectively, in vivo. Even in vitro there were conflicting data about binary or graded expression of CD25 and CD69 (<xref ref-type="bibr" rid="bib1">Allison et al., 2016</xref>; <xref ref-type="bibr" rid="bib8">Busse et al., 2010</xref>; <xref ref-type="bibr" rid="bib12">Feinerman et al., 2010</xref>; <xref ref-type="bibr" rid="bib14">Huang et al., 2013</xref>; <xref ref-type="bibr" rid="bib30">Podtschaske et al., 2007</xref>; <xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>). This is an interesting issue because binary responses are able to filter out noisy signals and can integrate different information to control cell responses. Thereby, binary responses allow parallel and independent control of single cell activation probability and population heterogeneity (<xref ref-type="bibr" rid="bib15">Kellogg et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Köck et al., 2014</xref>).</p><p>Here, we studied the antigen amount-driven regulation of IL-2 and CD25 expression at the single cell and population level as well as IL-2 signaling under the real spatial-temporal conditions of secondary lymphoid organs in vivo. Using a murine adoptive transfer model enabled us to study an antigen-specific T cell response in syngeneic recipient mice and cytokine secretion assays to measure the rate and magnitude of cytokine production of individual cells over time. In addition, mathematical modeling allowed us to compare the effects of the hypothesized graded and observed binary IL-2 expression for the first time. The model revealed advantages of the latter for a wide linear scaling of STAT5 activation in Treg and/or Th cells to antigen concentration. Finally, our results demonstrate that the combination of binary IL-2 secretion and graded CD25 expression at the cellular level enables the parallel control of single cell activation probability and population heterogeneity by the respective antigen amount.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Binary IL-2 production of Th cells in vivo after immunization</title><p>Previously, we showed in vitro that IL-2 is produced in a binary (‘digital’ or ‘all-or-none’) manner by Th cells (<xref ref-type="bibr" rid="bib30">Podtschaske et al., 2007</xref>), because variation of strength of the stimulation changed the number of IL-2 expressing cells rather than the intensity of IL-2 per cell. It is challenging to analyze whether this holds true in vivo, too.</p><p>To address this question, we adoptively transferred naïve transgenic Foxp3<sup>−</sup> CD4<sup>+</sup> T helper cells from DO11.10 mice into recipient mice and analyzed IL-2 production in the spleen using a cytokine secretion assay (<xref ref-type="bibr" rid="bib5">Assenmacher et al., 1998</xref>) 14 hr after immunization with ovalbumin (OVA). Different amounts of antigen used for immunization resulted in changes in the number of IL-2-producing cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, left), but almost no change in the mean fluorescence intensity (MFI) of IL-2 expression per Th cell (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, right). Thus, the amount of antigen correlates with the proportion of Th cells that produced IL-2, but does not change the amount of IL-2 per cell, which confirms that IL-2 production is regulated in a binary fashion in vivo, too. The IL-2 expression peaked between 6 and 18 hr (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The IL-2 secretion assay detected up to 75% IL-2-producing Th cells at the highest amount of antigen (2 mg) used. This number reflects the in vivo situation better than direct measurement of IL-2 by intracellular staining, which only detected maximally ~9% IL-2-producing Th cells, considered to be too low (<xref ref-type="bibr" rid="bib24">Long and Adler, 2006</xref>). Moreover, we excluded an underestimation of cytokine production by confirming that the cytokine capture matrix is not saturated in our experiments (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The data shown were generated with transfer of OVA-specific DO11.10 T cells (<xref ref-type="fig" rid="fig1">Figure 1</xref>), but were also reproduced using T cells from OT-II mice (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Our results were confirmed in a more thorough statistical analysis in which we explicitly tested for bimodality in IL-2 expression and used mixed gaussian models to extract expression values and percentages of cell subpopulations (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>).<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.20616.002</object-id><label>Figure 1.</label><caption><title>Binary IL-2 secretion of adoptively transferred Th cells in vivo after immunization with increasing amounts of antigen and kinetics of IL-2 secretion.</title><p>BALB/c mice, adoptively transferred with OVA-specific T cells from DO11.10 mice, were immunized intravenously with the indicated amounts of OVA and 10 μg LPS as adjuvant and analyzed 14 hr later (<bold>A</bold>–<bold>C</bold>) or with 2 mg OVA + 10 µg LPS and analyzed over time (<bold>D</bold>). IL-2 secretion of OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells was analyzed using the IL-2 secretion assay. Data from gated transgenic T cells (live B220<sup>−</sup> CD4<sup>+</sup> OVA-TCR<sup>+</sup> Foxp3<sup>−</sup>) were concatenated (3 mice per antigen dose). (<bold>A</bold>) IL-2 production was plotted against the amount of OVA used for immunization: Very left dot plot: fluorescence intensities of IL-2 per cell; left graph: frequencies of IL-2 producing cells; right histogram overlay: IL-2 fluorescence intensities (FI) for all gated OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells; very right histogram overlay: IL-2 producing OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells. (<bold>B</bold>) Similar analysis for the expression of CD25 on gated OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells. In the very right graph the mean fluorescence intensity (MFI) of CD25 is plotted against the amount of OVA. (<bold>C</bold>) Similar analysis for the expression of CD69 on gated OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells. CD69 expressing T cells were distinguished in antigen-specific activated CD69<sup>high</sup> and bystander-activated CD69<sup>intermediate</sup> expressing T cells. The gates for CD69<sup>intermediate</sup> and CD69<sup>high</sup> T cells were set according to unimmunized and non-transfer immunized controls. (<bold>D</bold>) IL-2 production (top row) and CD25 expression (bottom row) in OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells are plotted against time after immunization. Dot plots (left) depict fluorescence intensities per cell; the middle graphs depict frequencies of positive cells; the right graphs depict MFIs. Statistics: mean and standard deviation were plotted in all graphs. Data are representative of three independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.002">http://dx.doi.org/10.7554/eLife.20616.002</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig1-v1"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.20616.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>The cytokine capture matrix is not saturated by the endogenous IL-2 secretion.</title><p>C57BL/6 mice with adoptively transferred sorted naive (CD62L<sup>hi</sup>) CD4<sup>+</sup> T cells from OT-II mice were immunized intravenously with 2 mg OVA and 10 µg LPS as adjuvant and analyzed at 7 hr. (<bold>A</bold>) At the end of the secretion phase, 0.4 µg/ml exogenous recombinant IL-2 was added (right panel). Samples without recombinant IL-2 served as controls (left panel). (<bold>B</bold>) Transgenic IL-2-secreting CD4<sup>+</sup> T cells were determined using the cytokine secretion assay.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.003">http://dx.doi.org/10.7554/eLife.20616.003</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig1-figsupp1-v1"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.20616.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Binary IL-2 secretion of adoptively transferred OT-II Th cells in vivo after immunization with increasing amounts of antigen.</title><p>C57BL/6 mice, adoptively transferred with sorted naive (CD62L<sup>hi</sup>) OVA-specific CD4<sup>+</sup> T cells from OT-II mice, were immunized intravenously with the indicated amounts of OVA and 10 μg LPS as adjuvant and analysed at 14 hr (<bold>A</bold>–<bold>D</bold>). IL-2 secretion of Thy-1.1<sup>+</sup> CD4<sup>+</sup> T cells was analyzed using the IL-2 secretion assay. Data from gated transgenic T cells (live B220<sup>−</sup> CD4<sup>+</sup> Thy-1.1<sup>+</sup>) were concatenated (4 mice per antigen dose in A+B and 3 mice per antigen dose in C+D). (<bold>A</bold>) IL-2 production is plotted against the amount of OVA used for immunization: left dot plot: fluorescence intensities (FI) of IL-2 per Th cell; right figure: frequencies of IL-2 producing Th cells. (<bold>B</bold>) Histogram overlays of IL-2 fluorescence intensities for all gated transgenic Thy-1.1<sup>+</sup> CD4<sup>+</sup> T cells (left) as well as only for IL-2 producing Thy-1.1<sup>+</sup> CD4<sup>+</sup> T cells (right) are depicted. (<bold>C</bold>) CD25 expression is plotted against the amount of OVA used for immunization: fluorescence intensities of CD25 per Th cell in a dot plot (left) or a histogram overlay (right). (<bold>D</bold>) CD69 expression is plotted against the amount of OVA used for immunization: fluorescence intensities of CD69 per Th cell in a dot plot (left) or a histogram overlay (right). Data are representative of three independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.004">http://dx.doi.org/10.7554/eLife.20616.004</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig1-figsupp2-v1"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.20616.005</object-id><label>Figure 1—figure supplement 3.</label><caption><title>Confirmation of binary IL-2 expression using Gaussian mixture models.</title><p>Mode expression values are extracted as mean values of the components of a fitted Gaussian mixture model taking data of <xref ref-type="fig" rid="fig1">Figure 1</xref>, in (<bold>B</bold>) only 2 mice per group are depicted. Models with two mixture components are used only in case of significant bimodality (p&lt;0.05). (<bold>A</bold>) Plotted are significance of digital expression (upper left) and percentage of IL-2+ cells (upper right) as well as mode expression of CD25 (lower left) and CD69 (lower right) for the indicated amounts of OVA and 10 μg LPS after 14 hr. (<bold>B</bold>) Plotted are significance of digital expression (upper left) and percentage of IL-2+ cells (upper right) as well as mode expression of IL-2+/− (lower left) and CD25 (lower right) for the indicated time points after immunization with 2 mg OVA + 10 μg LPS. The low p-values for IL-2 indicate digital expression for strong immunization (OVA &gt; 125 μg) and between 3 and 12 hr after immunization. The subpopulations of IL-2+/− expression correspond to the mixture components with higher/lower mean. The percentage of IL-2+ cells corresponds to the relative weight of the mixture component with the higher mean. To test for digital expression we performed Hartigan's dip test statistic for unimodality on log-transformed FACS data using the R package ‘diptest’ (<ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=diptest">https://cran.r-project.org/package=diptest</ext-link>). The Gaussian mixture model fits were performed using the R package ‘mixtools’ (<ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=mixtools">https://cran.r-project.org/package=mixtools</ext-link>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.005">http://dx.doi.org/10.7554/eLife.20616.005</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig1-figsupp3-v1"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.20616.006</object-id><label>Figure 1—figure supplement 4.</label><caption><title>Transcriptional regulation of IL-2 secretion in adoptively transferred Th cells.</title><p>C57BL/6 mice with adoptively transferred sorted naive (CD62L<sup>hi</sup>) CD4<sup>+</sup> T cells from OT-II mice were immunized intravenously with increasing amounts of OVA and 10 μg LPS as adjuvant and analyzed at 7 hr. IL-2 secretion of Thy-1.1<sup>+</sup> cells was analyzed using the IL-2 secretion assay. Splenocytes were stained and analyzed by flow cytometry. Transgenic T cells were gated (live B220<sup>−</sup> CD4<sup>+</sup> Thy-1.1<sup>+</sup>), data from gated transgenic T cells were concatenated (4 mice per antigen dose), and the fluorescence intensity (FI) of c-Fos or NFATc2 was divided into quartiles having the same cell number (left: schematic diagram). Histogram overlays show the FI of IL-2 for each quartile and each transcription factor in samples from mice with increasing amounts of OVA (right). Data of one representative experiment out of two are shown.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.006">http://dx.doi.org/10.7554/eLife.20616.006</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig1-figsupp4-v1"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.20616.007</object-id><label>Figure 1—figure supplement 5.</label><caption><title>Expression levels of CD25 and CD69 on T cell subpopulations after immunization.</title><p>BALB/c mice with adoptively transferred sorted OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells from DO11.10 mice were immunized intravenously with increasing amounts of OVA and 10 μg LPS as adjuvant and analyzed at 14 hr. Data from gated endogenous and transgenic T cells (live B220<sup>−</sup> CD4<sup>+</sup> OVA-TCR<sup>+/−</sup> Foxp3<sup>+/−</sup>) were concatenated (3 mice per antigen dose). (<bold>A</bold>) CD25 expression on T cell subpopulations plotted against the amount of OVA used for immunization. Left graph shows frequencies of CD25<sup>+</sup> T cells and right graph the mean fluorescence intensity of CD25 expression on T cells. (<bold>B</bold>) CD69 expression on T cell subpopulations plotted against the amount of OVA used for immunization. Left graph shows frequencies of CD69<sup>high</sup> T cells representing antigen-specifically activated T cells, middle graph shows frequencies of CD69<sup>intermediate</sup> T cells representing bystander activated T cells, and right graph shows the mean fluorescence intensity (MFI) of CD69 expression on T cells. The gates for CD69<sup>intermediate</sup> and CD69<sup>high</sup> T cells were set according to unimmunized and non-transfer immunized controls as shown in <xref ref-type="fig" rid="fig1">Figure 1C</xref>. Statistics: mean and standard deviation were plotted in all graphs. Data are representative of three independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.007">http://dx.doi.org/10.7554/eLife.20616.007</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig1-figsupp5-v1"/></fig><fig id="fig1s6" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.20616.008</object-id><label>Figure 1—figure supplement 6.</label><caption><title>Expression levels of CD25 on T cell subpopulations at rest and after immunization.</title><p>BALB/c mice with adoptively transferred sorted OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells from DO11.10 mice were immunized intravenously with 2 mg OVA and 10 μg LPS as adjuvant and anaylzed at 14 hr or left unimmunized. CD25 expression levels were analyzed by histogram overlays of gated T cells (live B220<sup>−</sup> CD4<sup>+</sup> OVA-TCR<sup>+/−</sup> Foxp3<sup>+/−</sup>) without immunization (left) and after immunization (right). Data of three individual mice per antigen dose were concatenated. One representative experiment out of three is shown.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.008">http://dx.doi.org/10.7554/eLife.20616.008</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig1-figsupp6-v1"/></fig></fig-group></p><p>In parallel we studied whether the amount of the transcription factors c-Fos and NFATc2 limit the IL-2 production per mouse cell in vivo, as already shown in vitro for human peripheral blood memory Th cells (<xref ref-type="bibr" rid="bib30">Podtschaske et al., 2007</xref>). To this end we used adoptively transferred naïve transgenic CD4<sup>+</sup> T cells 7 hr after immunization of mice and co-stained c-Fos, NFATc2, and IL-2 using intracellular staining and cytokine secretion assays, respectively. Interestingly, only the amount of c-Fos but not of NFATc2 per Th cell correlates with the probability of IL-2 expression in vivo. Quartiles with the same cell number but different fluorescence intensities of c-Fos or NFATc2 (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>, left) showed that the probability of IL-2 production correlates with the c-Fos amount per cell but is independent of NFATc2 amounts within their physiological range (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>, right). This is in line with the observation of Allison et al. that the MEK/ERK/AP1 axis plays an important role in translating TCR signaling into proportional activation of genes essential for T cell function (<xref ref-type="bibr" rid="bib1">Allison et al., 2016</xref>).</p></sec><sec id="s2-2"><title>Graded IL-2Rα expression by Th cells in vivo after immunization</title><p>Next we analyzed how CD25, the high affinity IL-2Rα chain, is expressed in vivo. So far, in vitro quantitative single cell studies have produced conflicting results proposing opposite manners of CD25 expression, namely binary (<xref ref-type="bibr" rid="bib8">Busse et al., 2010</xref>) and graded (<xref ref-type="bibr" rid="bib12">Feinerman et al., 2010</xref>). Given that CD25 expression peaks between 12 and 24 hr after immunization (<xref ref-type="bibr" rid="bib22">Lischke et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Long and Adler, 2006</xref>), we observed graded CD25 and CD69 expression of adoptively transferred transgenic CD4<sup>+</sup> T cells 14 hr after immunization of mice. Different antigen concentrations used for immunization changed the mean fluorescence intensity (MFI) of CD25 expression per Th cell (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, right). The amount of antigen correlated with the amount of CD25 expressed per cell (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, left), and thus its ability to respond to IL-2. Notably, CD25 expression was up-regulated only by transferred antigen-specific Th and Treg cells (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplements 5A</xref> and <xref ref-type="fig" rid="fig1s6">6</xref>), but not by endogenous T cells. This fact is pointing to preferential up-regulation of CD25 expression via TCR-stimulated T cell activation. The same holds true for high expression of CD69 (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B</xref>). However, a small bystander expression of CD69 (CD69<sup>intermediate</sup> cells) was observed on endogenous Th and Treg cells after immunization of mice with OVA + LPS.</p><p>Next, we analyzed the kinetics of IL-2 secretion and CD25 expression in adoptively transferred transgenic Th cells after immunization of mice with 2 mg OVA + 10 µg LPS (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Both processes reached their maximum value between 3 to 6 hr and obviously CD25 protein expression persisted longer than IL-2 secretion.</p></sec><sec id="s2-3"><title>CD25 upregulation is similar in IL-2-producing and IL-2-nonproducing transgenic T cells in vivo</title><p>The amount of expression of CD25 is critical for Th cells in order to respond to IL-2, in particular if the IL-2 concentration is low (<xref ref-type="bibr" rid="bib8">Busse et al., 2010</xref>; <xref ref-type="bibr" rid="bib12">Feinerman et al., 2010</xref>; <xref ref-type="bibr" rid="bib31">Popmihajlov and Smith, 2008</xref>; <xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>). In contrast to Treg cells, Th cells show high expression of CD25 only transiently, due to the short duration of both, antigen-induced TCR signaling and IL-2/IL-2R signaling (<xref ref-type="bibr" rid="bib26">Malek and Castro, 2010</xref>; <xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>).</p><p>Interestingly, co-staining of CD25 and IL-2 in adoptively transferred transgenic Th cells (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, top row) revealed that the amount and variation of CD25 expression is similar in IL-2-producing and IL-2-nonproducing cells 14 hr after immunization with different antigen concentrations (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, bottom row). Accordingly, the kinetics of IL-2 secretion and CD25 expression in adoptively transferred transgenic Th cells after immunization of mice with 2 mg OVA + 10 µg LPS was similar in IL-2-producing and IL-2-nonproducing cells during the time of expression of both molecules (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). These data suggest that mainly the amount of antigen and a paracrine, rather than an autocrine, action of IL-2 regulates the expression of CD25 in vivo.<fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.20616.009</object-id><label>Figure 2.</label><caption><title>In vivo kinetics of IL-2 secretion and CD25 expression in adoptively transferred Th cells after immunization and their correlation upon titration of antigen amount as well as over time.</title><p>BALB/c mice, adoptively transferred with OVA-specific T cells from DO11.10 mice, were immunized intravenously with increasing amounts of OVA and 10 μg LPS as adjuvant and analyzed at 14 hr (<bold>A</bold>) or 2 mg OVA + 10 μg LPS and analyzed over time (<bold>B</bold>). IL-2 secretion of OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells was analyzed using the IL-2 secretion assay. Data from gated OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells (live B220<sup>−</sup> CD4<sup>+</sup> OVA-TCR<sup>+</sup> Foxp3<sup>−</sup>) were concatenated (3 mice per antigen dose or time point). (<bold>A</bold>) IL-2 production and CD25 expression (fluorescence intensities per cell) are depicted for increasing amounts of OVA used for immunization (top row, dot plots). A histogram overlay shows the IL-2 fluorescence intensities of gated OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells for different antigen amounts for direct comparison (bottom row, left). Histogram overlays of CD25 fluorescence intensities in IL-2 producing (red) and non-producing (black) OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells for individual OVA amounts are shown for direct comparison of CD25 expression (bottom row, right). (<bold>B</bold>) IL-2 production and CD25 expression (fluorescence intensities per cell) are depicted over time (top row, dot plots). A histogram overlay shows the IL-2 fluorescence intensities of gated OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells over time for direct comparison (bottom row, left). Histogram overlays of CD25 fluorescence intensities in IL-2 producing (red) and non-producing (black) OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells for individual time points are shown for direct comparison of CD25 expression (bottom row, right). Statistics: mean and standard deviation were plotted in all graphs. Data are representative of three independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.009">http://dx.doi.org/10.7554/eLife.20616.009</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig2-v1"/></fig></p></sec><sec id="s2-4"><title>Computational modeling suggests physiological advantages of binary IL-2 secretion</title><p>To get an idea about the physiological importance of binary IL-2 expression for activation of antigen-specific Th and Treg cells, we compared the observed binary IL-2 pattern to the hypothetical scenario of graded IL-2 secretion. The physiological consequences of different secretion patterns are not intuitively obvious and might depend on many factors such as the spatial distribution of cells in the spleen and on diffusion and secretion rates. Computational modeling allowed us to simulate the consequences of different hypothetical scenarios taking into account quantitative empirical information about the real system. All parameters of the model are listed in <xref ref-type="supplementary-material" rid="SD1-data">Supplementary file 1</xref> and the spatial distribution of T cells is depicted in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</p><p>Our computational model describes a population of T cells that can secrete IL-2 and/or express IL-2R at varying levels corresponding to the antigen stimulus. Cells are considered ‘activated’ when the amount of receptor-bound IL-2 exceeds a particular threshold. <xref ref-type="fig" rid="fig3">Figure 3A</xref> schematically represents the differences between the compared scenarios at low antigen concentrations. Intuitively, one might expect that activation of Th cells requires higher levels of antigen stimulus in the graded scenario because for IL-2 diffusion it is harder to overcome the critical distances between cells. It is not obvious, however, whether there are differences in the activation of Treg cells as they are able to sense very low concentrations of IL-2. The model can assist in making sense of or in correcting our intuitions.<fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.20616.010</object-id><label>Figure 3.</label><caption><title>Model and experimental validation of binary versus graded IL-2 production.</title><p>(<bold>A</bold>) Schematic representation for the effects of different modes of IL-2 secretion (red) by Th (blue) on surrounding Th (blue) and Treg (green) cells. Graded IL-2 secretion at low antigen dose (left) is compared to binary IL-2 secretion (right). IL-2 mediated T cell activation is depicted via conversion of quiescent CD25 (black Y) to activated CD25 (red Y). (<bold>B</bold>) Model and comparison to experiment: Diffusion of IL-2 and interaction of IL-2 and IL-2R is modeled for a population of T cells in the spleen. The figure depicts the fraction of T cells that have more than a critical amount IL-2 bound to IL-2R on their surface (and thus reach their activation threshold) and compares it to the fraction of p-STAT5<sup>+</sup> T cells in the experiment. (<bold>C</bold>) BALB/c mice, adoptively transferred with OVA-specific T cells from DO11.10 mice, were immunized intravenously with increasing amounts of OVA and 10 µg LPS as adjuvant. CD25 expression and STAT5 phosphorylation were analyzed after 14 hr on gated CD4<sup>+</sup> T cells (live B220<sup>−</sup> CD4<sup>+</sup> OVA-TCR<sup>+/−</sup> Foxp3<sup>+/−</sup>). Left figure: Dot plots of p-STAT5 versus CD25 expression for gated transgenic Th and Treg cells without immunization or after immunization with 2 mg OVA + 10 µg LPS. Right graph: Percentage of p-STAT5<sup>+</sup> signal in different T cell subpopulations versus amount of OVA used for immunization (3 mice per antigen dose). Statistics: mean and standard deviation were plotted. Data are representative of two independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.010">http://dx.doi.org/10.7554/eLife.20616.010</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig3-v1"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.20616.011</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Simulation model of binary versus graded IL-2 production.</title><p>Model of IL-2 mediated Th and Treg cell activation via CD25. IL-2 producing (P), IL-2 non-producing (N) T helper cells and regulatory T cells (R) are randomly distributed in a grid. The level of available IL-2 in the intercellular space is represented by a heatmap. T helper cells that become activated via the IL-2/CD25 axis, i.e. reaching the activation threshold, appear green, and regulatory T cells that become activated via the IL-2/CD25 axis appear pink. Graded and binary IL-2 secretion are simulated for increasing percentages of maximal antigen stimulus.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.011">http://dx.doi.org/10.7554/eLife.20616.011</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig3-figsupp1-v1"/></fig></fig-group></p><p>Our simulations show that in the binary scenario for IL-2 the number of activated Th and Treg cells slowly increases with increasing antigen stimulus, while the behaviour is rather switch-like in the graded case (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This can be understood in the following way: If secretion is graded (i.e. many producers), the distribution of IL-2 is relatively homogeneous across the whole volume. Consequently, all cells are exposed to similar levels of IL-2 and thus are either all activated or not in the graded IL-2 scenario. If secretion is binary (i.e. the number of secreting cells increases with increasing stimulus, the amount is constant), by contrast, then the number of activated cells increases more gradually because cells that are in close proximity to secreting cells are activated first. Binary secretion at the cellular level thus leads to graded activation at the population level and <italic>vice versa</italic>.</p><p>In summary, binary IL-2 and graded CD25 expression as well as higher CD25 expression by Treg cells ensures a fast action and wide linear antigen response range of Treg cells. Interestingly, the model simulations predict that Th cells are activated at lower antigen concentrations in the binary than in the graded scenario. However, Treg cells are always activated at lower antigen concentrations than Th cells. This is obviously important for effective control of autoimmunity ensuring Treg cell activation in spatial proximity even if only rare self-reactive IL-2 secreting Th cells exist (<xref ref-type="bibr" rid="bib23">Liu et al., 2015</xref>).</p></sec><sec id="s2-5"><title>Binary IL-2 secretion tailors the number of activated Th and Treg cells to the amount of antigen</title><p>To compare the model data with the in vivo situation, we analysed IL-2 signaling by STAT5 activation in antigen-specific T cells. We co-stained phosphorylated STAT5 and CD25 directly ex vivo in adoptively transferred antigen-specific Th and Treg cells 14 hr after immunization of mice. As expected, with increasing amounts of antigen (and hence increasing IL-2 secretion) STAT5 phosphorylation increased proportionally in antigen-specific Th and Treg cells. Moreover, antigen-specific Treg cells showed a much higher STAT5 phosphorylation than antigen-specific Th cells. However, the p-STAT5 signals were quite low. Even at the highest antigen concentration (2 mg OVA) only ~11% of Th cells stained positive for p-STAT5 despite the fact that about 75% of Th cells secrete IL-2 and about 95% express CD25 at this condition (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Within the Treg cell population about 50% were p-STAT5<sup>+</sup> (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). It is possible that p-STAT5<sup>+</sup> frequencies are underestimated due to difficulties in preserving the p-STAT5 signal during the preparation of cells ex vivo and the staining process. O’ Gorman et al. described that the induction of p-STAT5 is lower in naïve Th cells compared to repeatedly activated cells but lasts longer (<xref ref-type="bibr" rid="bib29">O'Gorman et al., 2009</xref>). In line with this, our endogenous antigen-unspecific Th cells had a very low expression of CD25 and almost no p-STAT5. In contrast, STAT5 activation (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) was observed at a similar degree on both Treg cell populations, transgenic (antigen-specific) and endogenous Treg cells.</p><p>To analyse whether the low p-STAT5 levels of antigen-specific Th cells are due to their unresponsiveness to IL-2 or because they do not have access to IL-2 in vivo, we treated mice with either recombinant IL-2 (20 μg) or IL-2-complex (2.5 μg IL-2 with 10 μg anti-IL-2 antibody JES6-5H4). Furthermore, we incubated one part of the spleen in vitro with IL-2 (200 ng recombinant IL-2 for 25 min). The data clearly show that neither IL-2 treatment of mice nor in vitro IL-2 treatment of Th cells increased STAT5 activation in transgenic Th cells (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Thus it is very probable that antigen-specific Th cells are unresponsive to IL-2 by negative crosstalk between antigen and IL-2 signaling as described before (<xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>; <xref ref-type="bibr" rid="bib41">Villarino et al., 2007</xref>; <xref ref-type="bibr" rid="bib43">Waysbort et al., 2013</xref>). Taken together, our model data are consistent with the experimental data (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) and reveal the importance of IL-2-activated Treg cells for limiting the immune response of Th cells. First, at low amounts of antigen (&lt;30 µg OVA) preferentially a proportion of Treg cells is activated by IL-2, and thus can limit the immune response at low danger. Second, binary IL-2 expression tailors the fraction of activated Treg cells proportionately to the antigen amount and avoids that all Treg cells are almost simultaneously activated as would be expected in the graded IL-2 expression scenario. Third, at low antigen amounts binary IL-2 expression ensures by its spatial distribution that only those antigen-specific and unspecific Treg cells are activated, which are in close spatial proximity to the few IL-2 producing Th cells. This is in good agreement with data of Liu et al. concerning observations on self tolerance (<xref ref-type="bibr" rid="bib23">Liu et al., 2015</xref>).<fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.20616.012</object-id><label>Figure 4.</label><caption><title>Treatment of mice with recombinant IL-2 does not increase STAT5 activation.</title><p>C57BL/6 mice, adoptively transferred with OVA-specific T cells from OT-II mice, were immunized intravenously with 2000 µg OVA and 10 µg LPS or were left unimmunized. After 12 hr mice received either 20 µg recombinant IL-2, 2.5 µg IL-2 complexed with 10 µg anti-IL-2 (JES6-5H4; targets IL-2 to CD122), or PBS as control. Mice were sacrificed 1 hr later. Cells from one part of the spleen were incubated for 25 min in vitro with 200 ng recombinant IL-2. (<bold>A</bold>) Representative original data (gated on transgenic CD4<sup>+</sup> T cells) are shown in the flow cytometric plots. (<bold>B</bold>) Percentage of p-STAT5<sup>+</sup> cells within either endogenous CD4<sup>+</sup> T cells (including FoxP3<sup>+</sup> cells) or transgenic FoxP3-negative CD4<sup>+</sup> T cells are depicted in bar graphs. Pooled data are from two independent experiments (together six mice per group). Error bars represent SEM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.012">http://dx.doi.org/10.7554/eLife.20616.012</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig4-v1"/></fig></p></sec><sec id="s2-6"><title>The ratio of antigen-specific Th and Treg cells remains stable over a wide antigen concentration range</title><p>Next, we investigated whether the observed preferential Treg cell activation at low antigen doses is translated into a higher expansion or survival rate compared to Th cells. Using the adoptive transfer model, we found that antigen-specific Th and Treg cells did not proliferate after immunization at low antigen concentrations (2–8 µg OVA) in CFSE dilution assays (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). In line with this, we observed similar total cell counts and relative frequencies as in the unimmunized controls under these conditions (<xref ref-type="fig" rid="fig5">Figure 5B,C</xref>). The percentage of dividing progenitors was approximately 10%, which appeared to be the background level already present in Th and Treg cells without immunization (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Above 8 µg OVA, total cell numbers of transgenic Th and Treg cells increased proportionally to the antigen amount, but with a dramatic different slope. CFSE dilution profiles revealed a stronger proliferative response of OVA-specific Th cells compared to Treg cells at higher concentrations. As an example, at 500 µg OVA 94% of Th cell progenitors were dividing compared to 65% of Treg cell progenitors (<xref ref-type="fig" rid="fig5">Figure 5D</xref>).<fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.20616.013</object-id><label>Figure 5.</label><caption><title>Dependency of in vivo proliferation rate of adoptively transferred Th and Treg cells on amount of antigen.</title><p>BALB/c mice, adoptively transferred with CFSE-labeled OVA-specific T cells from DO11.10 mice, were immunized intravenously with increasing amounts of OVA and 10 μg LPS as adjuvant and analyzed at 72 hr. Gated OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells (live B220<sup>−</sup> CD4<sup>+</sup> OVA-TCR<sup>+</sup> Foxp3<sup>+/−</sup>) were analyzed for CFSE dilution (2 mice per antigen dose). (<bold>A</bold>) Gating strategy for proliferation analysis: after doublet exclusion in FSC-A/FSC-H and SSC-A/SSC-H plots (not shown), cells were gated according to scatter characteristics, dead cells (Pacific Orange positive) were excluded, followed by gating on B220<sup>−</sup> CD4<sup>+</sup> OVA-TCR<sup>+</sup> Foxp3<sup>+/−</sup> T cells and analysis of CFSE dilution. (<bold>B</bold>) The total T cell count per spleen was calculated and plotted against amount of antigen for OVA-TCR<sup>+</sup> Foxp3<sup>−</sup> Th cells (blue circles) and OVA-TCR<sup>+</sup> Foxp3<sup>+</sup> Treg cells (green circles). (<bold>C</bold>) The relative frequencies of Foxp3<sup>−</sup> Th cells (blue circles) and Foxp3<sup>+</sup> Treg cells (green circles) in all transgenic OVA-TCR<sup>+</sup> T cells were plotted against amount of antigen. (<bold>D</bold>) Furthermore, the percentage of dividing cells of the progenitor cells (generation 0) was calculated and plotted against the amount of OVA used for immunization. Statistics: mean and standard deviation were plotted in all graphs. Data are representative of four independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.013">http://dx.doi.org/10.7554/eLife.20616.013</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig5-v1"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.20616.014</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Antigen-specific Treg cells show less apoptosis then conventional Th cells at low amounts of antigen.</title><p>BALB/c mice with adoptively transferred sorted OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells from DO11.10×DEREG mice were immunized intravenously with increasing amounts of OVA and 10 μg LPS as adjuvant and analyzed at 72 hr. Gated OVA-TCR<sup>+</sup> CD4<sup>+</sup> T cells (DAPI<sup>low</sup> B220<sup>−</sup> CD4<sup>+</sup> OVA-TCR<sup>+</sup> Foxp3-GFP<sup>+/−</sup>) were analyzed for AnnexinV and FLICA binding (3 mice per antigen dose). The total T cell count per spleen was calculated and plotted against the amount of antigen for OVA-TCR<sup>+</sup> Foxp3<sup>−</sup> Th cells (blue circles) and OVA-TCR<sup>+</sup> Foxp3<sup>+</sup> Treg cells (green circles). The percentage of apoptotic cells (AnnexinV<sup>+</sup> or FLICA<sup>+</sup>) amongst transgenic Th and Treg cells was plotted against the increasing amounts of OVA used for immunization. Statistics: individual data points and mean connecting line were plotted in both graphs. Data are representative of two independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.014">http://dx.doi.org/10.7554/eLife.20616.014</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-20616-fig5-figsupp1-v1"/></fig></fig-group></p><p>Subsequently, we analyzed the apoptosis rate of transferred antigen-specific Th and Treg cells 72 hr after immunization using annexin V binding (a marker for loss of cell membrane integrity upon apoptosis) (<xref ref-type="bibr" rid="bib40">Vermes et al., 1995</xref>) and FLICA staining (detecting activated caspases) (<xref ref-type="bibr" rid="bib36">Thornberry et al., 1997</xref>). In both assays, antigen-specific Treg cells showed less apoptosis than antigen-specific Th cells, in particular at low antigen concentrations (4–5% and 7–9% apoptotic cells, respectively, at 2–8 µg OVA). Apoptosis of Treg cells was proportionally increasing with the antigen amount up to the level of Th cells at 2000 µg OVA (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). In contrast, the apoptosis rate of antigen-specific Th cells was almost constant over the covered antigen concentration range.</p><p>Comparing cell counts at low antigen concentrations (2–8 µg OVA) (left parts of <xref ref-type="fig" rid="fig5">Figure 5B</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), it is obvious that apoptosis does not play an important role because T cell numbers were only slightly reduced at 72 hr. However, one must pay attention to the fact that apoptosis data represent only a momentary picture in the course of the immune response whereas proliferation analyses (CFSE dilution assay) are reflecting the whole process. In fact, the dilution of CFSE upon cell divisions reveals the proliferative history of the adoptively transferred T cells and reflects the total amount of proliferation that has occurred in the course of the immune response.</p><p>Altogether, the initial response to an antigen is characterized by antigen-specific IL-2 production of Th cells and an early activation of antigen-specific and endogenous Treg cells (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig3">3</xref>). At low antigen concentrations (up to 8 µg OVA) there is: (i) activation of Th and Treg cells, but (ii) almost no proliferation of all cells because neither Treg nor Th cells reach the activation threshold for entry into it, and (iii) a slightly lower apoptosis rate of Treg cells compared to Th cells. At higher concentrations (&gt;8 µg OVA) the cells expand proportionately to the antigen load, but it is obvious that living antigen-specific Th expand more than Treg cells (<xref ref-type="fig" rid="fig5">Figure 5B–D</xref>), which is in contrast to a previous report using IL-2 reporter mice (<xref ref-type="bibr" rid="bib4">Amado et al., 2013</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In order to contribute to the main question, how the adaptive immune system ensures tolerance at very low antigen concentration and adequate immune response at rising antigen amounts in respect of IL-2 expression and IL-2 action, we asked here: Is a graded antigen load translated into a binary or graded expression of the cytokine IL-2, the IL-2 receptor CD25, and the activation marker CD69 shortly after immunization of mice? Do binary processes indeed contribute to an enhanced robustness (<xref ref-type="bibr" rid="bib15">Kellogg et al., 2015</xref>) of antigen-specific activation of Th cells? Do binary processes support antigen amount-dependent Treg cell-mediated tolerance? Is IL-2 acting in a paracrine as well as autocrine fashion on CD25 expression?</p><p>Binding of IL-2 influences CD25 expression in Th cells as shown by several groups using single cell in vitro experiments including mathematical modeling (<xref ref-type="bibr" rid="bib8">Busse et al., 2010</xref>; <xref ref-type="bibr" rid="bib11">Feinerman et al., 2008</xref>; <xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>). IL-2 enhances TCR-induced up-regulation of CD25 level at suboptimal stimulation (<xref ref-type="bibr" rid="bib11">Feinerman et al., 2008</xref>). Our data clearly demonstrate a paracrine and ruled out a sole autocrine in vivo action of IL-2. Co-staining of CD25 and IL-2 revealed that IL-2-producing and IL-2-non-producing transgenic CD4<sup>+</sup> T cells have the same expression of CD25 at all the different antigen concentrations used (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and over the whole time frame of IL-2 and CD25 co-expression (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). These data are consistent with previous reports showing via STAT5 activation that IL-2 is delivered to neighboring T cells via synapses (<xref ref-type="bibr" rid="bib33">Sabatos et al., 2008</xref>) and that IL-2 production does not coincide with STAT5 phosphorylation (<xref ref-type="bibr" rid="bib24">Long and Adler, 2006</xref>). The observed peak times of IL-2 (6–14 hr) and CD25 (12–24 hr) show that IL-2 expression precedes CD25 expression in vivo, which is in good agreement with previous observations (<xref ref-type="bibr" rid="bib22">Lischke et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Long and Adler, 2006</xref>).</p><p>Beside the delivery of an important survival and maintenance signal for Treg cells, only a paracrine action of IL-2 allows in addition at least two other most recently discovered processes to occur. First, weaker T cell clones can be activated and proliferate just by integrating antigen and IL-2 response. Thus, IL-2 from strongly activated clones co-opt a fraction of weaker clones into activation and proliferation (<xref ref-type="bibr" rid="bib42">Voisinne et al., 2015</xref>) and contribute thereby to continuous heterogeneity of the responding population. Second, IL-2 may act as a gatekeeper for T cell homeostasis during an immune response, initiating the down-modulation of excessive or boosting of weak effector T cell responses by the interplay of Th and Treg cells (<xref ref-type="bibr" rid="bib3">Almeida et al., 2012</xref>, <xref ref-type="bibr" rid="bib2">2006</xref>; <xref ref-type="bibr" rid="bib4">Amado et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Reynolds et al., 2014</xref>).</p><p>In vitro studies claimed that many readouts downstream of TCR-activation such as IL-2, CD69, CD25, and ppERK are always binary (<xref ref-type="bibr" rid="bib12">Feinerman et al., 2010</xref>; <xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>). However, there are conflicting data from in vitro experiments concerning CD69 and CD25 expression (<xref ref-type="bibr" rid="bib1">Allison et al., 2016</xref>; <xref ref-type="bibr" rid="bib8">Busse et al., 2010</xref>; <xref ref-type="bibr" rid="bib12">Feinerman et al., 2010</xref>; <xref ref-type="bibr" rid="bib16">Kimmig and Baumgrass, 2009</xref>; <xref ref-type="bibr" rid="bib30">Podtschaske et al., 2007</xref>; <xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>). Using the adoptive transfer approach, we could confirm binary IL-2 expression in vivo, because the quantities of this cytokine on the cellular level were independent of the antigen concentrations used (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). However, we also found that the overall IL-2 responses were not binary but graded at the population level. Increasing antigen amount resulted in a proportional higher percentage of IL-2-producing T cells. Thus, increasing or decreasing the number of IL-2 producers and not regulating the magnitude of IL-2 output of individual cells calibrates the antigen response. Interestingly, unlike IL-2, and in contrast to some in vitro data, CD25 and CD69 expression is clearly graded in vivo at both, single cell and population level (<xref ref-type="fig" rid="fig1">Figure 1B,C</xref>) (<xref ref-type="bibr" rid="bib12">Feinerman et al., 2010</xref>; <xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>).</p><p>Binary responses of T cells play not just a role in filtering out noisy signals but moreover they can integrate information, such as timing or intensity, of the danger signal to adapt cell responses (<xref ref-type="bibr" rid="bib15">Kellogg et al., 2015</xref>). On the other hand, as discussed recently by Tkach et al., “binary single parameter readouts carry some limitations: they are prone to saturation of input detection range, exhibit narrow output dynamic ranges, are subject to shifts in value by cellular death and migration, and provide little information on the functional capacity of activated cells” (<xref ref-type="bibr" rid="bib38">Tkach et al., 2014</xref>).</p><p>Therefore, we asked whether the interplay of binary IL-2 and graded CD25 expression might have physiological advantages. To this end, we generated a computational model to compare the potential consequences of the observed binary and a hypothetical graded IL-2 secretion for the adaptive immune response. The model allowed us to simulate the outcome of these different scenarios taking into account quantitative spatial information in the spleen (<xref ref-type="bibr" rid="bib8">Busse et al., 2010</xref>; <xref ref-type="bibr" rid="bib9">Chapman et al., 1981</xref>; <xref ref-type="bibr" rid="bib22">Lischke et al., 2012</xref>; <xref ref-type="bibr" rid="bib28">Mueller and Germain, 2009</xref>; <xref ref-type="bibr" rid="bib33">Sabatos et al., 2008</xref>; <xref ref-type="bibr" rid="bib34">Smith, 2006</xref>). Our model confirmed that Treg cells become activated by IL-2 at lower antigen concentrations than Th cells and predicted that graded IL-2 secretion would result in activation of all T cells in a very narrow range of antigen stimulus, which is represented by a very steep slope of the activation curve of Th and Treg cells. Moreover, the binary IL-2 secretion results in a broadened linear range of initial T cell activation. This suits the needs of a fine-tuned immune response for a broad range of possible antigen loads.</p><p>Crucially, p-STAT5 measurements could substantiate our modeling results. Binary IL-2 secretion of Th cells led to a graded antigen dose-dependent increase in STAT5 phosphorylation in antigen-specific Th and Treg cells in vivo, which correlated perfectly with the activation curve of antigen-specific Th and Treg cells in our computational model. Very remarkably, not only the number of antigen-specific Treg cells but to a similar degree also endogenous Treg cells are p-STAT5 positive and correlate with the antigen amount. However, it is known that not only IL-2 signaling but also TCR signaling is required for the Treg cells to gain and sustain their full suppressive activity (<xref ref-type="bibr" rid="bib20">Levine et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Vahl et al., 2014</xref>).</p><p>Recently, Liu et al. provided information on how the spatial organization of IL-2-producing Th cells and activated Treg cells might help to maintain immune homeostasis (<xref ref-type="bibr" rid="bib23">Liu et al., 2015</xref>). Using imaging flow cytometry (histo-cytometry) they discovered that STAT5 was phosphorylated in most clustering Treg cells and that an IL-2-producing Th cell was usually at the center of Treg cell clusters. This study convincingly highlighted the role of spatial proximity of few IL-2 producing Th cells and clustering of Treg cells close to them for critical IL-2-driven immune regulatory processes. The reduction of motility of Th and Treg cells within the clusters could secure effective IL-2 delivery for Treg cells even if IL-2 is released in a non-directional manner. Moreover, the number of Treg cells within the cluster might determine how many Treg cells are affected. The point, how IL-2 is shared between Th and Treg cells is extensively studied and discussed in two recent theoretical articles (<xref ref-type="bibr" rid="bib18">Labowsky, 2016</xref>; <xref ref-type="bibr" rid="bib37">Thurley et al., 2015</xref>).</p><p>Almeida et al. deduced a central role for IL-2 in homeostasis of Th cells by indexing of Treg cells to the number of IL-2 producing cells resulting in a constant ratio of both in IL-2 reporter mice (<xref ref-type="bibr" rid="bib2">Almeida et al., 2006</xref>; <xref ref-type="bibr" rid="bib4">Amado et al., 2013</xref>). In contrast, we showed in our transfer model a higher increase in the number of antigen-specific Th cells compared to Treg cells over the antigen concentration range used (<xref ref-type="fig" rid="fig5">Figure 5B–D</xref>). Nevertheless, the interdependence of IL-2 producing cells and Treg cells allows immune responses but also feedback control.</p><p>Most recently, Chinen et al. proved the essential role of IL-2R-dependent activation of STAT5 in controlling suppressor function of mature Treg cells (<xref ref-type="bibr" rid="bib10">Chinen et al., 2016</xref>). Using genetic gain and loss of function approaches they demonstrated that augmented STAT5 activation in differentiated Treg cells increases the formation of Treg-DC-cell-conjugates and potentiates suppressor function in a TCR-independent manner.</p><p>In summary, we have shown that there are substantial differences between in vitro and in vivo experimental data concerning IL-2 and CD25 expression and regulation. Furthermore, we have demonstrated that computational modeling serves as a valuable and indispensable tool to understand complex regulatory mechanisms in vivo. Our insights contribute to a better understanding of antigen dose-dependent activation of the IL-2/CD25 axis of Th and Treg cells in an in vivo context and therefore under the real spatio-temporal conditions.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p>OVA-TCR transgenic OT-II mice (Jackson Laboratory, Bar Harbor, ME, Stock 004194) were crossed to B6PL mice (Jackson Stock 000406). OVA-TCR transgenic DO11.10 mice (Jackson Stock 003303) were for some experiments additionally crossed with DEREG mice (<xref ref-type="bibr" rid="bib19">Lahl et al., 2007</xref>) to obtain GFP reporter mice for Foxp3. All these mice including non-transgenic C57BL/6NCrl (Charles River, Sulzfeld, Germany, Strain Code 027) were bred under specific-pathogen-free conditions in the animal facility of the Federal Institute for Risk Assessment (Berlin, Germany). BALB/cAnNCrl mice were purchased from Charles River (Strain Code 028).</p></sec><sec id="s4-2"><title>Adoptive transfer</title><p>T cell receptor transgenic cells were isolated from spleens according to standard procedures. Naive OT-II cells were enriched by positive MACS sort with L-Selectin (CD62L) beads (Miltenyi Biotec, Bergisch Gladbach, Germany) and transferred into C57BL/6 mice (2.5–3.0 × 10<sup>6</sup> transgenic T cells per recipient). DO11.10 cells were depleted of CD8<sup>+</sup> cells by negative MACS sort with CD8 beads (Miltenyi Biotec) and transferred into BALB/c mice (1.0–1.5 × 10<sup>6</sup> transgenic T cells per recipient). To analyze proliferation, cells were labeled with CFSE (Invitrogen) before adoptive transfer, according to standard protocols. The mice were immunized intravenously with different amounts of endotoxin-free Ovalbumin (&lt;5 pg of endotoxin/mg of protein by Limulus amebocyte lysate assay) and 10 µg lipopolysaccharide (LPS, from <italic>E. coli</italic> O55:B5, Sigma-Aldrich, St. Louis, MO, USA) as adjuvant. For IL-2 in vivo treatment, mice received i.p. either 20 µg recombinant IL-2 or 2.5 µg IL-2 complexed with 10 µg anti-IL-2 (clone JES6-5H4 targets IL-2 to CD122). Splenocytes from C57BL/6 or BALB/c recipient mice were isolated and analyzed at indicated times after immunization.</p></sec><sec id="s4-3"><title>IL-2 secretion assay</title><p>IL-2 secretion assays (Miltenyi Biotech) were performed with 7.5 × 10<sup>6</sup> splenocytes from C57BL/6 mice as previously described (<xref ref-type="bibr" rid="bib5">Assenmacher et al., 1998</xref>). In brief, cells were washed, resuspended in ice-cold buffer (0.5% BSA, 2 mM EDTA in PBS) and incubated with the anti-IL-2 antibody capture matrix on ice for 5–10 min. After adding pre-warmed medium (RPMI 1640 + 4% FCS), cells were incubated at 37°C in a shaking water bath for 45 min. The secretion phase was stopped by adding ice cold PBS/BSA/EDTA buffer to the cells. IL-2 secreting cells were stained with anti-IL-2-PE antibody and different surface marker antibodies for 20 min on ice. To control whether the IL-2 capture matrix is saturated by endogenous IL-2 secretion, 0.4 µg/ml recombinant murine IL-2 (eBioscience) was added 5 min before the end of the secretion phase (see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p></sec><sec id="s4-4"><title>Flow cytometric analysis</title><p>Cell suspensions from spleen were counted with a Guava EasyCyte capillary flow cytometer and ViaCount Assay (Merck Millipore, Germany). For reduction of unspecific antibody binding, cells were preincubated with 100 µg/ml 2.4G2 (FcγRII/III; ATCC, Manassas, VA) and 50 μg/ml purified rat Ig (Nordic, Tilburg, The Netherlands) for 5 min. Surface staining was performed on ice for 20 min with monoclonal antibodies conjugated to FITC, PE, PerCP-Cy5.5, PE-Cy7, APC, AF700, and PacB: αCD4 (RM4-5), αCD25 (PC61.5), αB220 (RA3-6B2), αOVA-TCR (KJ1-26), αThy1.1 (OX-7; all purified from hybridoma supernatants), and αCD69 (H1.2F3; eBioscience, San Diego, CA, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_465119">AB_465119</ext-link>). Dead cells were excluded from analysis by DAPI (4-,6-diamidino-2-phenylindole) staining.</p><p>For detection of early apoptotic cells, either PE-conjugated annexin V (BioLegend, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2561298">AB_2561298</ext-link>) or an Alexa Fluor 660-labeled inhibitor of caspases (FLICA; Immunochemistry Technologies) was used in combination with DAPI.</p><p>When analyzing CFSE dilution profiles the percentage of dividing progenitors, i.e. the precursor frequency of dividing cells, was calculated as described (<xref ref-type="bibr" rid="bib25">Lyons and Parish, 1994</xref>).</p><p>For intracellular staining of the transcription factor p-STAT5 (Alexa Fluor 647-labeled antibody clone 47/p-STAT5, BD Biosciences) spleens were disintegrated directly into BD Fixation Buffer containing 2% paraformaldehyde and stained in BD Perm Buffer III (BD Biosciences) for 30 min on ice.</p><p>For intracellular staining of the transcription factors NFATc2 (Cy5-labeled own polyclonal antibodies (<xref ref-type="bibr" rid="bib7">Bendfeldt et al., 2012</xref>), c-Fos (Alexa Fluor 488-labeled rabbit polyclonal IgG antibodies from Santa Cruz Biotechnology, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2231996">AB_2231996</ext-link>), and Foxp3 (PE-Cy7-labeled antibody clone FJK-16s from eBioscience, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_891554">AB_891554</ext-link>) the cells were stained with 1.34 µM Pacific Orange succinimidyl ester to exclude dead cells, fixed with Foxp3 fixation buffer (eBioscience), stained in Foxp3 permeabilization buffer (eBioscience), and analyzed using a LSR II flow cytometer (BD Biosciences). Data were analyzed with FlowJo software (Treestar, Ashland, OR).</p></sec><sec id="s4-5"><title>Computational model</title><sec id="s4-5-1"><title>Basic features of the model</title><p>The model describes a population of T cells on a 2D circular domain (spleen/lymph node) and explicitly includes the secretion and diffusion of IL-2 and the formation of IL-2:IL-2R-complexes in space and time via a set of reaction-diffusion equations. Cells are modeled as circular areas with reactive boundaries that account for either secretion of IL-2 or IL-2:IL-2R-complex formation. Dirichlet boundary conditions were imposed on the outer boundary of the domain. The cells were distributed randomly with a mean cell-to-cell distance derived from considerations about the number of T cells and the size of the T cell zone in the spleen. The dynamics of IL-2:IL-2R-interactions on the cell boundaries was included in terms of a simple Michaelis-Menten type model which accounts for complex formation, dissociation and internalization. We assumed that the receptor dynamics can be approximated by considering only the influence of the expression of the high affinity chain CD25. The influence of unspecific CD25 positive cells was modeled in terms of a homogeneous background degradation of IL-2. The model was written and evaluated in MATLAB making use of the Partial Differential Equation Toolbox.</p></sec><sec id="s4-5-2"><title>Implementation of binary/graded scenarios</title><p>Binary (all-or-none) IL-2 secretion was implemented by randomly choosing a subset of producers that all secrete IL-2 at the maximal rate. In the graded scenario, by contrast, the maximum amount of producers secrete IL-2 at a rate that changes with increasing antigen stimulus. The fraction of producers in the binary case and the secretion rate in the graded case were chosen such that the total amount of IL-2 secreted is the same for both scenarios. The quantitative relationship between IL-2 secretion rate/CD25 expression and the antigen stimulus were determined by evaluating the corresponding FACS experiments (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s4-5-3"><title>Output of the model</title><p>Simulations were performed for varying antigen stimuli according to the doses used in the corresponding FACS experiments. For each stimulus the process was simulated over a time span of 48 hr which encompasses the initial increase and eventual decline of both IL-2 secretion and CD25 expression. In each simulation the distribution of cells and the random selection of producers/consumers was carried out anew. For each consumer cell the total amount of internalized complex was measured over the course of the simulation and taken as a proxy for downstream STAT5 signaling (not included in the model). We assumed that a cell is activated when the amount of complex exceeds a critical threshold. This threshold was chosen such as to optimize the fit between the fraction of activated cells in the model and the fraction of p-STAT5<sup>+</sup> cells in the experiment (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p></sec><sec id="s4-5-4"><title>Equations</title><p>The basic scheme of the diffusion equation used in the model is<disp-formula id="equ1"><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">∂</mml:mi><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>D</mml:mi><mml:mfrac><mml:mrow><mml:msup><mml:mi mathvariant="normal">∂</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">∂</mml:mi><mml:msup><mml:mi>x</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mi>d</mml:mi><mml:mi>U</mml:mi><mml:mi>R</mml:mi><mml:mspace width="thinmathspace"/><mml:mo>⋅</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mn>2</mml:mn><mml:mi>R</mml:mi><mml:mspace width="thinmathspace"/><mml:mo>⋅</mml:mo><mml:mspace width="thinmathspace"/><mml:mfrac><mml:mi>u</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mo>+</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>u</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> represents the solution for the concentration of IL-2 and is the diffusion coefficient. The second term on the right hand side accounts for the homogeneous background degradation due to unspecific regulatory cells. <italic>IL2R</italic> is the expression rate of CD25 and the factor <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>d</mml:mi><mml:mi>U</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> stands for the density of unspecific Tregs. The parameter <inline-formula><mml:math id="inf3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> can be interpreted as the concentration at which the consumption of IL-2 is half its maximum value. This parameter depends on the rates of formation, dissociation, and internalization of complexes in the following way:<disp-formula id="equ2"><mml:math id="m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>The secretion of IL-2 by producer cells was accounted for in terms of generalized Neumann conditions on the outer cell boundaries:<disp-formula id="equ3"><mml:math id="m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>n</mml:mi><mml:mo>⋅</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mi mathvariant="normal">∇</mml:mi><mml:mi>u</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mn>2</mml:mn><mml:mo>⋅</mml:mo><mml:mi>f</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>C</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> is the outward unit normal, <inline-formula><mml:math id="inf5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> the maximal secretion rate, and <inline-formula><mml:math id="inf6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>c</mml:mi><mml:mi>C</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> the cell circumference. The factor <inline-formula><mml:math id="inf7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>f</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> accounts for the dependence of the secretion rate on the antigen stimulus and the time after stimulation. Dependence on time was modeled as the composition of a linearly increasing function from 0 to the maximum value between t = 0 and t = 9 hr and a linearly decreasing function from the maximum to 0 between t = 9 hr and t = 18 hr (compare to <xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>The interaction of IL-2 and IL-2R on the surface of consumer cells is also accounted for in terms of generalized Neumann boundary conditions:<disp-formula id="equ4"><mml:math id="m4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>n</mml:mi><mml:mo>⋅</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mi mathvariant="normal">∇</mml:mi><mml:mi>u</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>−</mml:mo><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mn>2</mml:mn><mml:mi>R</mml:mi><mml:mo>⋅</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>C</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac><mml:mo>⋅</mml:mo><mml:mfrac><mml:mi>u</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mo>+</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>Here, <inline-formula><mml:math id="inf8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mn>2</mml:mn><mml:mi>R</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> denotes the maximal expression of CD25, while <inline-formula><mml:math id="inf9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>g</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> accounts for the dependence of CD25 expression on stimulus and time. Time dependence in this case was modeled as a linear increase between t = 0 and t = 18 hr and a subsequent decrease between t = 18 hr and t = 30. The dependence of CD25 expression on the antigen stimulus is different for T helper cells and regulatory T cells and was determined by evaluating the corresponding FACS experiments.</p></sec></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Tim Sparwasser, Jochen Hühn, Ute Hoffmann and Alf Hamann for providing DO11.10×DEREG mice. We are grateful to the staff of the animal facility and the labmanagers. We thank Jenny Kirsch and Toralf Kaiser, operators of the flow cytometry core facility (FCCF). We thank Melanie Venzke, Christian Gabriel, Manja Jargosch, Anna Abajyan, Martin Karl, Katharina Hecklau, Stefanie Gryzik and Yen Hoang for lively discussion and helpful advices.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>FF, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con2"><p>TL, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con3"><p>FG, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con4"><p>TS, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con5"><p>LB, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con6"><p>KWK, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con7"><p>AR, Conception and design, Drafting or revising the article</p></fn><fn fn-type="con" id="con8"><p>HH, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con9"><p>AH, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con10"><p>RB, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: All animal experiments were performed according to state guidelines and approved by the responsible governmental authority LAGeSo (Landesamt für Gesundheit und Soziales) Berlin in animal experiment licenses T 0187/01 and G 0070/13.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.20616.015</object-id><label>Supplementary file 1:</label><caption><title>Parameter estimates for the mathematical model.</title><p>Parameter names, symbols and values used for the mathematical modeling are given.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20616.015">http://dx.doi.org/10.7554/eLife.20616.015</ext-link></p></caption><media mime-subtype="msword" mimetype="application" xlink:href="elife-20616-supp1-v1.doc"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>KA</given-names></name><name><surname>Sajti</surname><given-names>E</given-names></name><name><surname>Collier</surname><given-names>JG</given-names></name><name><surname>Gosselin</surname><given-names>D</given-names></name><name><surname>Troutman</surname><given-names>TD</given-names></name><name><surname>Stone</surname><given-names>EL</given-names></name><name><surname>Hedrick</surname><given-names>SM</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells</article-title><source>eLife</source><volume>5</volume><elocation-id>10134</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.10134</pub-id><pub-id pub-id-type="pmid">27376549</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>AR</given-names></name><name><surname>Zaragoza</surname><given-names>B</given-names></name><name><surname>Freitas</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells</article-title><source>The Journal of Immunology</source><volume>177</volume><fpage>192</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.1.192</pub-id><pub-id pub-id-type="pmid">16785514</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>AR</given-names></name><name><surname>Amado</surname><given-names>IF</given-names></name><name><surname>Reynolds</surname><given-names>J</given-names></name><name><surname>Berges</surname><given-names>J</given-names></name><name><surname>Lythe</surname><given-names>G</given-names></name><name><surname>Molina-París</surname><given-names>C</given-names></name><name><surname>Freitas</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Quorum-sensing in CD4(+) T cell homeostasis: a hypothesis and a model</article-title><source>Frontiers in Immunology</source><volume>3</volume><elocation-id>125</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2012.00125</pub-id><pub-id pub-id-type="pmid">22654881</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amado</surname><given-names>IF</given-names></name><name><surname>Berges</surname><given-names>J</given-names></name><name><surname>Luther</surname><given-names>RJ</given-names></name><name><surname>Mailhé</surname><given-names>MP</given-names></name><name><surname>Garcia</surname><given-names>S</given-names></name><name><surname>Bandeira</surname><given-names>A</given-names></name><name><surname>Weaver</surname><given-names>C</given-names></name><name><surname>Liston</surname><given-names>A</given-names></name><name><surname>Freitas</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IL-2 coordinates IL-2-producing and regulatory T cell interplay</article-title><source>The Journal of Experimental Medicine</source><volume>210</volume><fpage>2707</fpage><lpage>2720</lpage><pub-id pub-id-type="doi">10.1084/jem.20122759</pub-id><pub-id pub-id-type="pmid">24249704</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assenmacher</surname><given-names>M</given-names></name><name><surname>Löhning</surname><given-names>M</given-names></name><name><surname>Scheffold</surname><given-names>A</given-names></name><name><surname>Manz</surname><given-names>RA</given-names></name><name><surname>Schmitz</surname><given-names>J</given-names></name><name><surname>Radbruch</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Sequential production of IL-2, IFN-gamma and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes</article-title><source>European Journal of Immunology</source><volume>28</volume><fpage>1534</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199805)28:05&lt;1534::AID-IMMU1534&gt;3.0.CO;2-R</pub-id><pub-id pub-id-type="pmid">9603458</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benary</surname><given-names>M</given-names></name><name><surname>Bendfeldt</surname><given-names>H</given-names></name><name><surname>Baumgrass</surname><given-names>R</given-names></name><name><surname>Herzel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Modeling IL-2 gene expression in human regulatory T cells</article-title><source>Genome Informatics. International Conference on Genome Informatics</source><volume>20</volume><fpage>222</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1142/9781848163003_0019</pub-id><pub-id pub-id-type="pmid">19425136</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendfeldt</surname><given-names>H</given-names></name><name><surname>Benary</surname><given-names>M</given-names></name><name><surname>Scheel</surname><given-names>T</given-names></name><name><surname>Frischbutter</surname><given-names>S</given-names></name><name><surname>Abajyan</surname><given-names>A</given-names></name><name><surname>Radbruch</surname><given-names>A</given-names></name><name><surname>Herzel</surname><given-names>H</given-names></name><name><surname>Baumgrass</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stable IL-2 decision making by endogenous c-Fos amounts in peripheral memory T-helper cells</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>18386</fpage><lpage>18397</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.358853</pub-id><pub-id pub-id-type="pmid">22474330</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busse</surname><given-names>D</given-names></name><name><surname>de la Rosa</surname><given-names>M</given-names></name><name><surname>Hobiger</surname><given-names>K</given-names></name><name><surname>Thurley</surname><given-names>K</given-names></name><name><surname>Flossdorf</surname><given-names>M</given-names></name><name><surname>Scheffold</surname><given-names>A</given-names></name><name><surname>Höfer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments</article-title><source>PNAS</source><volume>107</volume><fpage>3058</fpage><lpage>3063</lpage><pub-id pub-id-type="doi">10.1073/pnas.0812851107</pub-id><pub-id pub-id-type="pmid">20133667</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>EH</given-names></name><name><surname>Kurec</surname><given-names>AS</given-names></name><name><surname>Davey</surname><given-names>FR</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Cell volumes of normal and malignant mononuclear cells</article-title><source>Journal of Clinical Pathology</source><volume>34</volume><fpage>1083</fpage><lpage>1090</lpage><pub-id pub-id-type="doi">10.1136/jcp.34.10.1083</pub-id><pub-id pub-id-type="pmid">6975780</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinen</surname><given-names>T</given-names></name><name><surname>Kannan</surname><given-names>AK</given-names></name><name><surname>Levine</surname><given-names>AG</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Klein</surname><given-names>U</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Gasteiger</surname><given-names>G</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Fontenot</surname><given-names>JD</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An essential role for the IL-2 receptor in Treg cell function</article-title><source>Nature Immunology</source><volume>17</volume><fpage>1322</fpage><lpage>1333</lpage><pub-id pub-id-type="doi">10.1038/ni.3540</pub-id><pub-id pub-id-type="pmid">27595233</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feinerman</surname><given-names>O</given-names></name><name><surname>Veiga</surname><given-names>J</given-names></name><name><surname>Dorfman</surname><given-names>JR</given-names></name><name><surname>Germain</surname><given-names>RN</given-names></name><name><surname>Altan-Bonnet</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Variability and robustness in T cell activation from regulated heterogeneity in protein levels</article-title><source>Science</source><volume>321</volume><fpage>1081</fpage><lpage>1084</lpage><pub-id pub-id-type="doi">10.1126/science.1158013</pub-id><pub-id pub-id-type="pmid">18719282</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feinerman</surname><given-names>O</given-names></name><name><surname>Jentsch</surname><given-names>G</given-names></name><name><surname>Tkach</surname><given-names>KE</given-names></name><name><surname>Coward</surname><given-names>JW</given-names></name><name><surname>Hathorn</surname><given-names>MM</given-names></name><name><surname>Sneddon</surname><given-names>MW</given-names></name><name><surname>Emonet</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name><name><surname>Altan-Bonnet</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response</article-title><source>Molecular Systems Biology</source><volume>6</volume><elocation-id>437</elocation-id><pub-id pub-id-type="doi">10.1038/msb.2010.90</pub-id><pub-id pub-id-type="pmid">21119631</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottschalk</surname><given-names>RA</given-names></name><name><surname>Hathorn</surname><given-names>MM</given-names></name><name><surname>Beuneu</surname><given-names>H</given-names></name><name><surname>Corse</surname><given-names>E</given-names></name><name><surname>Dustin</surname><given-names>ML</given-names></name><name><surname>Altan-Bonnet</surname><given-names>G</given-names></name><name><surname>Allison</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses</article-title><source>PNAS</source><volume>109</volume><fpage>881</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1073/pnas.1119763109</pub-id><pub-id pub-id-type="pmid">22223661</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Brameshuber</surname><given-names>M</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>QJ</given-names></name><name><surname>Chien</surname><given-names>YH</given-names></name><name><surname>Valitutti</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A single peptide-major histocompatibility complex ligand triggers digital cytokine secretion in CD4(+) T cells</article-title><source>Immunity</source><volume>39</volume><fpage>846</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.036</pub-id><pub-id pub-id-type="pmid">24120362</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellogg</surname><given-names>RA</given-names></name><name><surname>Tian</surname><given-names>C</given-names></name><name><surname>Lipniacki</surname><given-names>T</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name><name><surname>Tay</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Digital signaling decouples activation probability and population heterogeneity</article-title><source>eLife</source><volume>4</volume><elocation-id>08931</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.08931</pub-id><pub-id pub-id-type="pmid">26488364</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmig</surname><given-names>S</given-names></name><name><surname>Baumgrass</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Biological switches: the 'all-or-none' principle in T-cell activation</article-title><source>Zeitschrift Fur Rheumatologie</source><volume>68</volume><fpage>560</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1007/s00393-009-0495-6</pub-id><pub-id pub-id-type="pmid">19585132</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köck</surname><given-names>J</given-names></name><name><surname>Kreher</surname><given-names>S</given-names></name><name><surname>Lehmann</surname><given-names>K</given-names></name><name><surname>Riedel</surname><given-names>R</given-names></name><name><surname>Bardua</surname><given-names>M</given-names></name><name><surname>Lischke</surname><given-names>T</given-names></name><name><surname>Jargosch</surname><given-names>M</given-names></name><name><surname>Haftmann</surname><given-names>C</given-names></name><name><surname>Bendfeldt</surname><given-names>H</given-names></name><name><surname>Hatam</surname><given-names>F</given-names></name><name><surname>Mashreghi</surname><given-names>MF</given-names></name><name><surname>Baumgrass</surname><given-names>R</given-names></name><name><surname>Radbruch</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>HD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Nuclear factor of activated T cells regulates the expression of interleukin-4 in Th2 cells in an all-or-none fashion</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><fpage>26752</fpage><lpage>26761</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.587865</pub-id><pub-id pub-id-type="pmid">25037220</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labowsky</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An analysis of early-stage IL-2 capture times in populations of T cells diffusively interacting in a confined environment</article-title><source>Journal of Theoretical Biology</source><volume>411</volume><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2016.09.010</pub-id><pub-id pub-id-type="pmid">27633715</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahl</surname><given-names>K</given-names></name><name><surname>Loddenkemper</surname><given-names>C</given-names></name><name><surname>Drouin</surname><given-names>C</given-names></name><name><surname>Freyer</surname><given-names>J</given-names></name><name><surname>Arnason</surname><given-names>J</given-names></name><name><surname>Eberl</surname><given-names>G</given-names></name><name><surname>Hamann</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name><name><surname>Huehn</surname><given-names>J</given-names></name><name><surname>Sparwasser</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease</article-title><source>The Journal of Experimental Medicine</source><volume>204</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1084/jem.20061852</pub-id><pub-id pub-id-type="pmid">17200412</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>AG</given-names></name><name><surname>Arvey</surname><given-names>A</given-names></name><name><surname>Jin</surname><given-names>W</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Continuous requirement for the TCR in regulatory T cell function</article-title><source>Nature Immunology</source><volume>15</volume><fpage>1070</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1038/ni.3004</pub-id><pub-id pub-id-type="pmid">25263123</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>W</given-names></name><name><surname>Lin</surname><given-names>JX</given-names></name><name><surname>Leonard</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy</article-title><source>Immunity</source><volume>38</volume><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.01.004</pub-id><pub-id pub-id-type="pmid">23352221</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lischke</surname><given-names>T</given-names></name><name><surname>Hegemann</surname><given-names>A</given-names></name><name><surname>Gurka</surname><given-names>S</given-names></name><name><surname>Vu Van</surname><given-names>D</given-names></name><name><surname>Burmeister</surname><given-names>Y</given-names></name><name><surname>Lam</surname><given-names>KP</given-names></name><name><surname>Kershaw</surname><given-names>O</given-names></name><name><surname>Mollenkopf</surname><given-names>HJ</given-names></name><name><surname>Mages</surname><given-names>HW</given-names></name><name><surname>Hutloff</surname><given-names>A</given-names></name><name><surname>Kroczek</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Comprehensive analysis of CD4+ T cells in the decision between tolerance and immunity in vivo reveals a pivotal role for ICOS</article-title><source>The Journal of Immunology</source><volume>189</volume><fpage>234</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1102034</pub-id><pub-id pub-id-type="pmid">22661090</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Gerner</surname><given-names>MY</given-names></name><name><surname>Van Panhuys</surname><given-names>N</given-names></name><name><surname>Levine</surname><given-names>AG</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name><name><surname>Germain</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune homeostasis enforced by co-localized effector and regulatory T cells</article-title><source>Nature</source><volume>528</volume><fpage>225</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1038/nature16169</pub-id><pub-id pub-id-type="pmid">26605524</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>M</given-names></name><name><surname>Adler</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response</article-title><source>The Journal of Immunology</source><volume>177</volume><fpage>4257</fpage><lpage>4261</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.7.4257</pub-id><pub-id pub-id-type="pmid">16982857</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>AB</given-names></name><name><surname>Parish</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Determination of lymphocyte division by flow cytometry</article-title><source>Journal of Immunological Methods</source><volume>171</volume><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(94)90236-4</pub-id><pub-id pub-id-type="pmid">8176234</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malek</surname><given-names>TR</given-names></name><name><surname>Castro</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Interleukin-2 receptor signaling: at the interface between tolerance and immunity</article-title><source>Immunity</source><volume>33</volume><fpage>153</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.08.004</pub-id><pub-id pub-id-type="pmid">20732639</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miskov-Zivanov</surname><given-names>N</given-names></name><name><surname>Turner</surname><given-names>MS</given-names></name><name><surname>Kane</surname><given-names>LP</given-names></name><name><surname>Morel</surname><given-names>PA</given-names></name><name><surname>Faeder</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The duration of T cell stimulation is a critical determinant of cell fate and plasticity</article-title><source>Science Signaling</source><volume>6</volume><elocation-id>ra97</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2004217</pub-id><pub-id pub-id-type="pmid">24194584</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>SN</given-names></name><name><surname>Germain</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Stromal cell contributions to the homeostasis and functionality of the immune system</article-title><source>Nature Reviews. Immunology</source><volume>9</volume><fpage>618</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1038/nri2588</pub-id><pub-id pub-id-type="pmid">19644499</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Gorman</surname><given-names>WE</given-names></name><name><surname>Dooms</surname><given-names>H</given-names></name><name><surname>Thorne</surname><given-names>SH</given-names></name><name><surname>Kuswanto</surname><given-names>WF</given-names></name><name><surname>Simonds</surname><given-names>EF</given-names></name><name><surname>Krutzik</surname><given-names>PO</given-names></name><name><surname>Nolan</surname><given-names>GP</given-names></name><name><surname>Abbas</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The initial phase of an immune response functions to activate regulatory T cells</article-title><source>The Journal of Immunology</source><volume>183</volume><fpage>332</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900691</pub-id><pub-id pub-id-type="pmid">19542444</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podtschaske</surname><given-names>M</given-names></name><name><surname>Benary</surname><given-names>U</given-names></name><name><surname>Zwinger</surname><given-names>S</given-names></name><name><surname>Höfer</surname><given-names>T</given-names></name><name><surname>Radbruch</surname><given-names>A</given-names></name><name><surname>Baumgrass</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Digital NFATc2 activation per cell transforms graded T cell receptor activation into an all-or-none IL-2 expression</article-title><source>PLoS One</source><volume>2</volume><elocation-id>e935</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0000935</pub-id><pub-id pub-id-type="pmid">17895976</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popmihajlov</surname><given-names>Z</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Negative feedback regulation of T cells via interleukin-2 and FOXP3 reciprocity</article-title><source>PLoS One</source><volume>3</volume><elocation-id>e1581</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0001581</pub-id><pub-id pub-id-type="pmid">18324310</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>J</given-names></name><name><surname>Amado</surname><given-names>IF</given-names></name><name><surname>Freitas</surname><given-names>AA</given-names></name><name><surname>Lythe</surname><given-names>G</given-names></name><name><surname>Molina-París</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A mathematical perspective on CD4(+) T cell quorum-sensing</article-title><source>Journal of Theoretical Biology</source><volume>347</volume><fpage>160</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2013.12.019</pub-id><pub-id pub-id-type="pmid">24389364</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatos</surname><given-names>CA</given-names></name><name><surname>Doh</surname><given-names>J</given-names></name><name><surname>Chakravarti</surname><given-names>S</given-names></name><name><surname>Friedman</surname><given-names>RS</given-names></name><name><surname>Pandurangi</surname><given-names>PG</given-names></name><name><surname>Tooley</surname><given-names>AJ</given-names></name><name><surname>Krummel</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A synaptic basis for paracrine interleukin-2 signaling during homotypic T cell interaction</article-title><source>Immunity</source><volume>29</volume><fpage>238</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.05.017</pub-id><pub-id pub-id-type="pmid">18674934</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The quantal theory of immunity</article-title><source>Cell Research</source><volume>16</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1038/sj.cr.7310003</pub-id><pub-id pub-id-type="pmid">16467871</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sojka</surname><given-names>DK</given-names></name><name><surname>Bruniquel</surname><given-names>D</given-names></name><name><surname>Schwartz</surname><given-names>RH</given-names></name><name><surname>Singh</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>IL-2 secretion by CD4+ T cells in vivo is rapid, transient, and influenced by TCR-specific competition</article-title><source>The Journal of Immunology</source><volume>172</volume><fpage>6136</fpage><lpage>6143</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.10.6136</pub-id><pub-id pub-id-type="pmid">15128800</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornberry</surname><given-names>NA</given-names></name><name><surname>Rano</surname><given-names>TA</given-names></name><name><surname>Peterson</surname><given-names>EP</given-names></name><name><surname>Rasper</surname><given-names>DM</given-names></name><name><surname>Timkey</surname><given-names>T</given-names></name><name><surname>Garcia-Calvo</surname><given-names>M</given-names></name><name><surname>Houtzager</surname><given-names>VM</given-names></name><name><surname>Nordstrom</surname><given-names>PA</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Vaillancourt</surname><given-names>JP</given-names></name><name><surname>Chapman</surname><given-names>KT</given-names></name><name><surname>Nicholson</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>A combinatorial approach defines specificities of members of the caspase family and granzyme B. functional relationships established for key mediators of apoptosis</article-title><source>Journal of Biological Chemistry</source><volume>272</volume><fpage>17907</fpage><lpage>17911</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.29.17907</pub-id><pub-id pub-id-type="pmid">9218414</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurley</surname><given-names>K</given-names></name><name><surname>Gerecht</surname><given-names>D</given-names></name><name><surname>Friedmann</surname><given-names>E</given-names></name><name><surname>Höfer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Three-Dimensional gradients of cytokine signaling between T cells</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004206</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004206</pub-id><pub-id pub-id-type="pmid">25923703</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tkach</surname><given-names>KE</given-names></name><name><surname>Barik</surname><given-names>D</given-names></name><name><surname>Voisinne</surname><given-names>G</given-names></name><name><surname>Malandro</surname><given-names>N</given-names></name><name><surname>Hathorn</surname><given-names>MM</given-names></name><name><surname>Cotari</surname><given-names>JW</given-names></name><name><surname>Vogel</surname><given-names>R</given-names></name><name><surname>Merghoub</surname><given-names>T</given-names></name><name><surname>Wolchok</surname><given-names>J</given-names></name><name><surname>Krichevsky</surname><given-names>O</given-names></name><name><surname>Altan-Bonnet</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>T cells translate individual, quantal activation into collective, analog cytokine responses via time-integrated feedbacks</article-title><source>eLife</source><volume>3</volume><fpage>e01944</fpage><pub-id pub-id-type="doi">10.7554/eLife.01944</pub-id><pub-id pub-id-type="pmid">24719192</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahl</surname><given-names>JC</given-names></name><name><surname>Drees</surname><given-names>C</given-names></name><name><surname>Heger</surname><given-names>K</given-names></name><name><surname>Heink</surname><given-names>S</given-names></name><name><surname>Fischer</surname><given-names>JC</given-names></name><name><surname>Nedjic</surname><given-names>J</given-names></name><name><surname>Ohkura</surname><given-names>N</given-names></name><name><surname>Morikawa</surname><given-names>H</given-names></name><name><surname>Poeck</surname><given-names>H</given-names></name><name><surname>Schallenberg</surname><given-names>S</given-names></name><name><surname>Rieß</surname><given-names>D</given-names></name><name><surname>Hein</surname><given-names>MY</given-names></name><name><surname>Buch</surname><given-names>T</given-names></name><name><surname>Polic</surname><given-names>B</given-names></name><name><surname>Schönle</surname><given-names>A</given-names></name><name><surname>Zeiser</surname><given-names>R</given-names></name><name><surname>Schmitt-Gräff</surname><given-names>A</given-names></name><name><surname>Kretschmer</surname><given-names>K</given-names></name><name><surname>Klein</surname><given-names>L</given-names></name><name><surname>Korn</surname><given-names>T</given-names></name><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Schmidt-Supprian</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Continuous T cell receptor signals maintain a functional regulatory T cell pool</article-title><source>Immunity</source><volume>41</volume><fpage>722</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.10.012</pub-id><pub-id pub-id-type="pmid">25464853</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermes</surname><given-names>I</given-names></name><name><surname>Haanen</surname><given-names>C</given-names></name><name><surname>Steffens-Nakken</surname><given-names>H</given-names></name><name><surname>Reutelingsperger</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V</article-title><source>Journal of Immunological Methods</source><volume>184</volume><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(95)00072-I</pub-id><pub-id pub-id-type="pmid">7622868</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villarino</surname><given-names>AV</given-names></name><name><surname>Tato</surname><given-names>CM</given-names></name><name><surname>Stumhofer</surname><given-names>JS</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Cui</surname><given-names>YK</given-names></name><name><surname>Hennighausen</surname><given-names>L</given-names></name><name><surname>O'Shea</surname><given-names>JJ</given-names></name><name><surname>Hunter</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals</article-title><source>The Journal of Experimental Medicine</source><volume>204</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1084/jem.20061198</pub-id><pub-id pub-id-type="pmid">17227909</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voisinne</surname><given-names>G</given-names></name><name><surname>Nixon</surname><given-names>BG</given-names></name><name><surname>Melbinger</surname><given-names>A</given-names></name><name><surname>Gasteiger</surname><given-names>G</given-names></name><name><surname>Vergassola</surname><given-names>M</given-names></name><name><surname>Altan-Bonnet</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>T cells integrate local and global cues to discriminate between structurally similar antigens</article-title><source>Cell Reports</source><volume>11</volume><fpage>1208</fpage><lpage>1219</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.04.051</pub-id><pub-id pub-id-type="pmid">26004178</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waysbort</surname><given-names>N</given-names></name><name><surname>Russ</surname><given-names>D</given-names></name><name><surname>Chain</surname><given-names>BM</given-names></name><name><surname>Friedman</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Coupled IL-2-dependent extracellular feedbacks govern two distinct consecutive phases of CD4 T cell activation</article-title><source>The Journal of Immunology</source><volume>191</volume><fpage>5822</fpage><lpage>5830</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301575</pub-id><pub-id pub-id-type="pmid">24244020</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.20616.016</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dustin</surname><given-names>Michael L</given-names></name><role>Reviewing editor</role><aff id="aff6"><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Adequate immune response ensured by binary IL-2 and graded CD25 expression in vivo&quot; for consideration by <italic>eLife</italic>. Your article has been favorably evaluated by Tadatsugu Taniguchi (Senior Editor) and three reviewers, one of whom, Michael L Dustin (Reviewer #1), is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal their identity: Kendall A Smith (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>This paper sets out to clarify how T cells scale their response to MHC-peptide dose at the level of IL-2 production, IL-2 response, IL-2 consumption, Treg activation and proliferation in vivo. It provides a culmination of &gt;35 years of research on how the cytokine IL-2 and its receptor make a profound contribution to shaping the T cell response. They re-evaluate the in vivo dose response and time course of IL-2 production, CD25 expression, CD69 expression and proliferation in vivo using DO11.10 and OTII TCR transgenic systems. They claim that IL-2 production is binary (see below)- that as antigen dose increases, the proportion of T cells making a fixed amount of IL-2 over several hours increases. In contrast, CD25 and CD69 responses are reported that all responding T cells make a response proportional to the input antigen dose. While experiments like this have been done before, the results for both IL-2 production and CD25 expression have been reported to be binary or graded in different studies so it was important to clarify the results in vivo using well defined models. They then apply a 2D model the T cell zone to the data to better understand the mechanism by which the combination of a binary IL-2 production and graded IL-2 responsiveness combine to generate a proliferative response in Th that is proportional to the antigen input. To make their case, they use a previously-published computational model of IL-2 dynamics [1] to resolve this paradox: by controlling the number of cells that secrete IL-2 in a graded manner, the system avoids homogenization, adjusts the number of Treg involved in suppressing the response, and establish a nice analog response. Such illuminating insight comes at the time when immunologists are dwelling on issues of scaling and global regulation: Fuhrmann et al. provide a very thorough analysis (both from the experimental and theoretical point of view).</p><p>Essential revisions:</p><p>1) The analysis of the digitalness of T cell activation in the experiment is partially satisfactory. The data speak for themselves (<xref ref-type="fig" rid="fig1">Figure 1</xref>) but a better analysis of the data would apply Gaussian Mixture Models to extract the mode of IL-2 secretion or CD25 expression amongst the activated cells. A more complete statistical analysis to demonstrate when/how a dual vs. single mode of activation applies (cf <xref ref-type="fig" rid="fig2">Figure 2</xref> in [2]).</p><p>2) One issue that this article seems to stumble open is about the distribution of pSTAT5 in response to IL-2 (cf <xref ref-type="fig" rid="fig3">Figure 3</xref>). Fuhrmann et al. report that the frequency of STAT5 phosphorylating cells is very small in conditions when a large fraction of cells is secreting IL-2. This can be well accounted for when taking into consideration the reported negative crosstalk between antigen signaling and IL-2 signaling [3-6]. Such negative crosstalk has already been invoked to explain some of the paradoxical features of STAT5 activation in T cells [3, 4], as well as scaling in IL-2 secretion. One control experiment would help clarify this issue: injecting a large dose of IL-2 or IL-2 complexed with a stimulatory antibody, then monitoring STAT5 phosphorylation would distinguish whether T cells are unresponsive to IL-2 or do not have access to IL-2. Blocking TCR signaling (e.g. using a blocking antibody against CD4) would also resolve whether there is an antigen-dependent active block on IL-2 signaling in vivo.</p><p>3) Throughout the manuscript, antigen &quot;strength&quot; is referred to, but the reader is left with no molecular definition of this mysterious &quot;strength&quot;. Since these experiments were performed with TCR transgenic cells, each cellular TCR is monoclonal. Thus, the affinity between the TCR and pMHC complexes is identical on all cells. Consequently, to account for the [antigen] log/dose response curve, isn't the differences on the part of the responses seen due to a log/normal distribution of [TCR] per cell?</p><p>References:</p><p>1) Busse, D., et al., Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proc Natl Acad Sci U S A, 2010. 107(7): p. 3058-63.</p><p>2) Shalek, A.K., et al., Single-cell RNA-seq reveals dynamic paracrine control of cellular variation. Nature, 2014. 510(7505): p. 363-9.</p><p>3) Long, M. and A.J. Adler, Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response. J Immunol, 2006. 177(7): p. 4257-61.</p><p>4) Villarino, A.V., et al., Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J Exp Med, 2007. 204(1): p. 65-71.</p><p>5) Waysbort, N., et al., Coupled IL-2-dependent extracellular feedbacks govern two distinct consecutive phases of CD4 T cell activation. J Immunol, 2013. 191(12): p. 5822-30.</p><p>6) Tkach, K.E., et al., T cells translate individual, quantal activation into collective, analog cytokine responses via time-integrated feedbacks. <italic>ELife</italic>, 2014. 3: p. e01944.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.20616.017</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>Essential revisions:</italic> </p><p><italic>1) The analysis of the digitalness of T cell activation in the experiment is partially satisfactory. The data speak for themselves (<xref ref-type="fig" rid="fig1">Figure 1</xref>) but a better analysis of the data would apply Gaussian Mixture Models to extract the mode of IL-2 secretion or CD25 expression amongst the activated cells. A more complete statistical analysis to demonstrate when/how a dual vs. single mode of activation applies (cf <xref ref-type="fig" rid="fig2">Figure 2</xref> in [2]).</italic> </p><p>As recommended, we performed an analysis based on Gaussian mixture models to extract the modes of expression and percentages of activated IL-2 cells. We tried several options to demonstrate bimodality (model selection using AIC/BIC, Silverman test, dip test). Only the dip test statistic provided satisfactory results, whereas the other methods seemed too sensitive, for example detecting significant mulitmodality due to spurious modes in the data. We used mixture models with two components only if the test revealed significant bimodality.</p><p>We inserted the data as a novel supplementary figure (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>: Confirmation of binary IL-2 expression using Gaussian mixture models) and a paragraph into the manuscript.</p><p><italic>2) One issue that this article seems to stumble open is about the distribution of pSTAT5 in response to IL-2 (cf <xref ref-type="fig" rid="fig3">Figure 3</xref>). Fuhrmann et al. report that the frequency of STAT5 phosphorylating cells is very small in conditions when a large fraction of cells is secreting IL-2. This can be well accounted for when taking into consideration the reported negative crosstalk between antigen signaling and IL-2 signaling [3-6]. Such negative crosstalk has already been invoked to explain some of the paradoxical features of STAT5 activation in T cells [3, 4], as well as scaling in IL-2 secretion. One control experiment would help clarify this issue: injecting a large dose of IL-2 or IL-2 complexed with a stimulatory antibody, then monitoring STAT5 phosphorylation would distinguish whether T cells are unresponsive to IL-2 or do not have access to IL-2. Blocking TCR signaling (e.g. using a blocking antibody against CD4) would also resolve whether there is an antigen-dependent active block on IL-2 signaling</italic> in vivo.</p><p>We took the reviewer’s suggestion and provided additional experiments to shed some light into this issue. We included a novel figure (<xref ref-type="fig" rid="fig4">Figure 4</xref>) and a paragraph into the manuscript:</p><p>“To analyze whether the low pSTAT5 levels of antigen-specific Th cells are due to their unresponsiveness to IL-2 or because they do not have access to IL-2 in vivo, we treated mice with either recombinant IL-2 (20 µg) or IL-2-complex (2.5 µg IL-2 with 10 µg anti-IL-2 antibody JES6-5H4). […] Thus it is very probable that antigen-specific Th cells are unresponsive to IL-2 by negative crosstalk between antigen and IL-2 signaling as described before (Tkach et al., 2014; Villarino et al., 2007; Waysbort et al., 2013).”</p><p><italic>3) Throughout the manuscript, antigen &quot;strength&quot; is referred to, but the reader is left with no molecular definition of this mysterious &quot;strength&quot;. Since these experiments were performed with TCR transgenic cells, each cellular TCR is monoclonal. Thus, the affinity between the TCR and pMHC complexes is identical on all cells. Consequently, to account for the [antigen] log/dose response curve, isn't the differences on the part of the responses seen due to a log/normal distribution of [TCR] per cell?</italic> </p><p>We thank the reviewer for the advice and changed it into “amount of antigen”.</p><p><italic>References:</italic> </p><p><italic>1) Busse, D., et al., Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proc Natl Acad Sci U S A, 2010. 107(7): p. 3058-63.</italic> </p><p><italic>2) Shalek, A.K., et al., Single-cell RNA-seq reveals dynamic paracrine control of cellular variation. Nature, 2014. 510(7505): p. 363-9.</italic> </p><p><italic>3) Long, M. and A.J. Adler, Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response. J Immunol, 2006. 177(7): p. 4257-61.</italic> </p><p><italic>4) Villarino, A.V., et al., Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J Exp Med, 2007. 204(1): p. 65-71.</italic> </p><p><italic>5) Waysbort, N., et al., Coupled IL-2-dependent extracellular feedbacks govern two distinct consecutive phases of CD4 T cell activation. J Immunol, 2013. 191(12): p. 5822-30.</italic> </p><p><italic>6) Tkach, K.E., et al., T cells translate individual, quantal activation into collective, analog cytokine responses via time-integrated feedbacks. ELife, 2014. 3: p. e01944.</italic> </p></body></sub-article></article>